Table 3 Distribution of inflammation-based prognostic scores among groups
Prognostic score | All patients (n = 1501) | Survival patients (n = 1155) | All-cause mortality (n = 346) | CVD mortality (n = 168) |
|---|---|---|---|---|
GPS | ||||
 0 | 909 (60.6%) | 845 (73.2%) | 64 (18.5%) | 26 (15.5%) |
 1 | 456 (30.4%) | 272 (23.5%) | 184 (53.2%) | 89 (53.0%) |
 2 | 136 (9.1%) | 38 (3.3%) | 98 (28.3%) | 53 (31.5%) |
PNI | ||||
 0 | 604 (40.2%) | 537 (46.5%) | 67 (19.4%) | 29 (17.3%) |
 1 | 897 (59.8%) | 618 (53.5%) | 279 (80.6%) | 139 (82.7%) |
PI | ||||
 0 | 1213 (80.8%) | 1016 (88.0%) | 197 (56.9%) | 89 (53.0%) |
 1 | 253 (16.9%) | 130 (11.3%) | 123 (35.6%) | 68 (40.5%) |
 2 | 35 (2.3%) | 9 (0.8%) | 26 (7.5%) | 11 (6.5%) |